PALIPERIDONE (is an active metabolite) | PALIPERIDONE | ATC N05AX13
NERVOUS SYSTEM ANTIPSYCHOTIC SCHIZOPHRENIA BENZISOXAZOLE DERIVATIVES DOPAMINE D2 RECEPTOR ANTAGONIST SEROTONIN TYPE 2 (5HT2A) RECEPTOR ANTAGONIST | ORAL | Tmax 3 HOUR VD 391 LITER PPB 74 PERCENT Cl 10.8 LITER / HOUR (EQN) HT 25 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | 5-HYDROXYTRYPTAMINE 2A RECEPTOR D(2) DOPAMINE RECEPTOR ALPHA1 ADRENERGIC RECEPTOR ALPHA2 ADRENERGIC RECEPTOR H1 HISTAMINERGIC RECEPTOR | DOPAMINE D2 RECEPTOR ANTAGONIST CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |